comparemela.com
Home
Live Updates
GSK posts blowout RSV vaccine sales, raises outlook as shots give big pharma a boost : comparemela.com
GSK posts blowout RSV vaccine sales, raises outlook as shots give big pharma a boost
The RSV shot, called Arexvy, booked £1.2 billion, or $1.5 billion, in sales after only being on the market for roughly half a year.
Related Keywords
Japan ,
United Kingdom ,
Canada ,
British ,
Albert Bourla ,
Emma Walmsley ,
Pfizer ,
Drug Administration ,
Chief Executive Officer Emma Walmsley ,
News ,
comparemela.com © 2020. All Rights Reserved.